» Articles » PMID: 20182032

Caffeine and the Control of Cerebral Hemodynamics

Overview
Publisher Sage Publications
Specialties Geriatrics
Neurology
Date 2010 Feb 26
PMID 20182032
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

While the influence of caffeine on the regulation of brain perfusion has been the subject of multiple publications, the mechanisms involved in that regulation remain unclear. To some extent, that uncertainty is a function of a complex interplay of processes arising from multiple targets of caffeine located on a variety of different cells, many of which have influence, either directly or indirectly, on cerebral vascular smooth muscle tone. Adding to that complexity are the target-specific functional changes that may occur when comparing acute and chronic caffeine exposure. In the present review, we discuss some of the mechanisms behind caffeine influences on cerebrovascular function. The major effects of caffeine on the cerebral circulation can largely be ascribed to its inhibitory effects on adenosine receptors. Herein, we focus mostly on the A1, A2A, and A2B subtypes located in cells comprising the neurovascular unit (neurons, astrocytes, vascular smooth muscle); their roles in the coupling of increased neuronal (synaptic) activity to vasodilation; how caffeine, through blockade of these receptors, may interfere with the "neurovascular coupling" process; and receptor-linked changes that may occur in cerebrovascular regulation when comparing acute to chronic caffeine intake.

Citing Articles

Investigating the acute cognitive effects of dietary compounds using fNIRS: methodological limitations and perspectives for research targeting healthy adults.

Zahar S, Van De Ville D, Hudry J Front Hum Neurosci. 2024; 18:1493880.

PMID: 39698147 PMC: 11652482. DOI: 10.3389/fnhum.2024.1493880.


Physiological influences on neurovascular coupling: A systematic review of multimodal imaging approaches and recommendations for future study designs.

Burma J, Bailey D, Johnson N, Griffiths J, Burkart J, Soligon C Exp Physiol. 2024; 110(1):23-41.

PMID: 39392865 PMC: 11689421. DOI: 10.1113/EP092060.


Reproducibility of cerebral perfusion measurements using BOLD delay.

Khalil A, Tanritanir A, Grittner U, Kirilina E, Villringer A, Fiebach J Hum Brain Mapp. 2023; 44(7):2778-2789.

PMID: 36840928 PMC: 10089099. DOI: 10.1002/hbm.26244.


Effects of Chronic Caffeine Consumption on Synaptic Function, Metabolism and Adenosine Modulation in Different Brain Areas.

Lopes C, Oliveira A, Gaspar I, Rodrigues M, Santos J, Szabo E Biomolecules. 2023; 13(1).

PMID: 36671491 PMC: 9855869. DOI: 10.3390/biom13010106.


Mental Performance and Sport: Caffeine and Co-consumed Bioactive Ingredients.

Kennedy D, Wightman E Sports Med. 2022; 52(Suppl 1):69-90.

PMID: 36447122 PMC: 9734217. DOI: 10.1007/s40279-022-01796-8.


References
1.
Arendash G, Schleif W, Rezai-Zadeh K, Jackson E, Zacharia L, Cracchiolo J . Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production. Neuroscience. 2006; 142(4):941-52. DOI: 10.1016/j.neuroscience.2006.07.021. View

2.
Ciruela F, Casado V, Rodrigues R, Lujan R, Burgueno J, Canals M . Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers. J Neurosci. 2006; 26(7):2080-7. PMC: 6674939. DOI: 10.1523/JNEUROSCI.3574-05.2006. View

3.
Jacobson K, Von Lubitz D, Daly J, Fredholm B . Adenosine receptor ligands: differences with acute versus chronic treatment. Trends Pharmacol Sci. 1996; 17(3):108-13. PMC: 3431161. DOI: 10.1016/0165-6147(96)10002-x. View

4.
Verkhratsky A, Verkhrasky A, Krishtal O, Burnstock G . Purinoceptors on neuroglia. Mol Neurobiol. 2009; 39(3):190-208. DOI: 10.1007/s12035-009-8063-2. View

5.
Watson J, Deary I, Kerr D . Central and peripheral effects of sustained caffeine use: tolerance is incomplete. Br J Clin Pharmacol. 2002; 54(4):400-6. PMC: 1874449. DOI: 10.1046/j.1365-2125.2002.01681.x. View